Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

In a US cohort study, hospital inpatient diversity was linked to improved gastrointestinal outcomes in Hispanic and Native American patients.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.